361
Participants
Start Date
March 31, 2012
Primary Completion Date
June 30, 2016
Study Completion Date
December 31, 2016
Enoxaparin
40 mg (4000 IU) women \<80 kg at the time of randomization or 60 mg (6000 IU) women\> 80 kg at the time of randomization One dose daily. Subcutaneous administration. Treatment periods: the same day of the Initiation visit (from 9 to 13.6 weeks of gestation) until 36 weeks gestation.
Hospital de Cruces, Barakaldo
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Sant Joan de Deu, Esplugues de Llobregat
Parc sanitari Sant Joan de Deu, Sant Boi de Llobregat
Hospital Vall d'Hebron
OTHER
Hospital Sant Joan de Deu
OTHER
Hospital de Cruces
OTHER
Parc Sanitari Sant Joan de Déu
OTHER
Hospital Universitari Vall d'Hebron Research Institute
OTHER